Introduction
============

Various diagnostic imaging modalities have been used for calculation of left ventricular (LV) volume. Two-dimensional (2D) echocardiography is most widely used technology, but it is suboptimal for detection of LV volume due to the complex LV cavity geometry. In ultrasonographic assessment of LV volumes, current 2D echo-cardiographic methods to quantitate ventricular performance require image acquisition from standardized scanning planes. LV volume is calculated from assumptions that the ventricular cavity can be represented by individual geometric figures or their combination. Both limitations of acoustic access and distortion of ventricular shape may invalidate these assumptions of standardized imaging planes and geometry, and lead to errors in calculating ventricular volume ([@b33-vhrm-4-1069]).

Regional diversity of LV may be a difficulty of echocardiographic volume assessment in clinical practice. It has been shown that simplified echocardiographic reconstruction used in conjunction with tissue harmonic imaging and automated endocardial border extraction accurately calculates LV volume and function in patients with regional wall motion abnormalities or distorted LVs caused by ischemic heart disease ([@b21-vhrm-4-1069]). 3D ultrasonographic imaging provides improved accuracy for LV volume and function compared with current 2D algorithms ([@b31-vhrm-4-1069]; [@b26-vhrm-4-1069]). In 3D reconstruction, the technique required many cardiac cycles to reconstruct the heart, with considerable artifact due to respiratory and patient movement ([@b28-vhrm-4-1069]). An integrated system may provide better agreement between LV volumes calculated by 3D reconstruction and actual volumes ([@b14-vhrm-4-1069]).

Increased LV volumes are associated with high mortality, adverse cardiovascular events, and worse prognosis ([@b31-vhrm-4-1069]). Although LV volumes have important prognostic implications, its evaluation is commonly underestimated in practice. If it is evaluated accurately, it provides additional incremental value to risk assessment and guides further therapy. Real-time 3D echocardiography has been compared with TI-201 single photon emission computed tomography (SPECT), cardiac magnetic resonance imaging (MRI) and found to be accurate and reproducible for the measurement of LV volumes for risk assessment in ischemic heart disease and dilated cardiomyopathy ([@b5-vhrm-4-1069]).

Determination of regional LV diversity is the main difficulty not only for ischemic heart disease and volume overload, but for hypertrophied hearts. The novel modality by application of real-time 3D imaging technology can improve understanding of the spatial relations of various cardiac structures and offers the potential for more accurate volumetric quantization ([@b12-vhrm-4-1069]). We previously have used real-time 3D imaging to evaluate total and segmental LV volume in patients with LV hypertrophy and have described the details in regional geometry and global LV morphology ([@b35-vhrm-4-1069]). Using 3D volumetric data, it has become possible to evaluate regional and global LV geometries especially in patients with LV geometric distortion or complex LV morphology. However, 3D approach is not a widely used echocardiographic method in clinical practice.

SPECT is one of the diagnostic modalities to evaluate LV volumetric and functional parameters accurately provided by gated myocardial perfusion tomographic slices. Gated perfusion tomographic slices have been used for volume calculations which includes 2D geometric assumptions and 3D approaches. Geometric modeling has been used for manually 2D calculation of ejection fraction (EF) using gated myocardial perfusion SPECT which has provided acceptable correlation with equilibrium multigated blood-pool and with contrast ventriculography ([@b7-vhrm-4-1069]; [@b23-vhrm-4-1069]). In healthy young subjects, post-exercise cardiac changes affect systolic functions detected on gated thallium myocardial perfusion scintigraphy, resulting in a smaller heart size during stress. However, the absence of these findings in the elderly suggests a decrease in contractility with age ([@b1-vhrm-4-1069]). In addition to aging, decreased contractility may be detected by gated myocardial perfusion SPECT in postischemic stunning due to stress-induced ischemic episode ([@b16-vhrm-4-1069]). Therefore, [@b16-vhrm-4-1069] suggested that the presence of post-ischemic reduction in the post-stress EF may be another marker of disease severity and reduced event-free survival.

It was also reported that gated myocardial perfusion SPECT with Tc-99m labeled radiopharmaceutical may provide more objective imaging data than Tl-201 because gated SPECT performed with Tc-99m labeled radiopharmaceutical gives better image quality than Tl-201 due to higher myo-cardial count rate. So when objective myocardial function monitoring is needed Tc-99m labeled radiopharmaceutical could be a reasonable method ([@b15-vhrm-4-1069]).

The number of gated frames per cardiac cycle in myo-cardial gated SPECT may influence the accuracy of both EF and wall thickening. It has been shown that an 8-frame study results in a mismall constant and predictable decrease of 0.04 in EF compared with a 16-frame study ([@b11-vhrm-4-1069]). First pass radionuclide venticulography is another imaging modality for EF calculations in which 32 frames per cardiac cycle are used. Despite high frame numbers, first pass radionuclide venticulography has some practical limitations like giving functional data only at the time of injection ([@b36-vhrm-4-1069]). Gated myocardial perfusion SPECT has been used with automated technology and has given a satisfactory result ([@b24-vhrm-4-1069]). It has been shown that automated edge-detection algorithm is well correlated with contrast left ventriculogram and MRI ([@b23-vhrm-4-1069]; [@b36-vhrm-4-1069]).

Planar multigated acquisition is one of the most common used technologies for EF and volume calculation. However, it is difficult to calculate EF of the ventricules due to atrial overlap so SPECT studies are widely used ([@b19-vhrm-4-1069]). On the other hand, SPECT studies are not successful in right ventricular EF calculation which is feasibly evaluated by first pass radionuclide ventriculography ([@b20-vhrm-4-1069]). Also in multigated SPECT ventriculography, we could not obtain an idea of the perfusion of the myocardium even if we can begin imaging a few hours later, which differs from first pass radionuclide ventriculography in which imaging must began as soon as possible after injection (Borges-Neto 1997). In the literature, it is stated that gated myocardial perfusion SPECT which gives perfusion in addition to EF and wall motion analysis is superior to gated blood pool SPECT ([@b22-vhrm-4-1069]).

Especially in coronary artery disease (CAD) patients, gated myocardial perfusion SPECT gives us more information than other technologies used for EF and volume calculations. With the quantitative gated SPECT (QGS) method, even in normal perfusion, we can detect wall motion abnormalities which will influence the survival of CAD patients ([@b32-vhrm-4-1069]). It has been documented that despite small systematic differences, agreement between gated myocardial SPECT and MRI is good over a wide range of volumes and EF values using the QGS method ([@b30-vhrm-4-1069]).

The variables provided by exercise radionuclide angiocardiography predicts cardiac death in patients with CAD ([@b17-vhrm-4-1069]). However, noninvasive assessment of EF usually has been found to be lower than that detected by angiography ([@b25-vhrm-4-1069]; [@b34-vhrm-4-1069]; [@b13-vhrm-4-1069]). Despite lower EF values by noninvasive assessment, noninvasive techniques are accurate in determination of normal and depressed EF ([@b13-vhrm-4-1069]). The quantification of influence of filtering and pixel size parameters on measured LV volumes for gated blood pool SPECT may be beneficial in correction of overestimation ([@b6-vhrm-4-1069]). SPECT has shown a slightly lower EF than that measured by echocardiography ([@b34-vhrm-4-1069]; [@b13-vhrm-4-1069]), this could be also caused by diverse population studied ([@b2-vhrm-4-1069]).

SPECT with boundary detection method also has shown a good correlation with equilibrium multigated blood-pool and MRI volumes ([@b8-vhrm-4-1069], [@b9-vhrm-4-1069]). Detection of boundaries for volume calculations may be possible in patients who have defect extending more than 25% of the myocardium ([@b24-vhrm-4-1069]). Border detection becomes more complicated in apical defects, it has been forced the wall to be a smooth connection between noninfarcted portions of the wall ([@b10-vhrm-4-1069]). Finally, positron emission tomography from nuclear studies has been used accurately for global and regional detection of LV function ([@b18-vhrm-4-1069]). It has given an acceptable result for LV volumes and EF in comparison with MRI and angiography ([@b29-vhrm-4-1069]). Among the noninvasive modalities, MRI is considered the gold standard, because of high accuracy and reproducibility for volume measurements ([@b3-vhrm-4-1069]). It has been used for assessment of myocardial thickness and regional myocardial function quantitatively ([@b27-vhrm-4-1069]).

In conclusion, gated myocardial perfusion SPECT is feasible for evaluation of LV volume and functional analysis in routine clinical practice. MRI preserves its importance in selected patients to determine more precise LV geometric data in patients with cardiac diseases, but it is unfortunately more expensive to use routinely.
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